NO921472D0 - Fremgangsmaate for fremstilling av rna-virus fra cdna - Google Patents

Fremgangsmaate for fremstilling av rna-virus fra cdna

Info

Publication number
NO921472D0
NO921472D0 NO1992921472A NO921472A NO921472D0 NO 921472 D0 NO921472 D0 NO 921472D0 NO 1992921472 A NO1992921472 A NO 1992921472A NO 921472 A NO921472 A NO 921472A NO 921472 D0 NO921472 D0 NO 921472D0
Authority
NO
Norway
Prior art keywords
cdna
rna virus
methods
procedure
producing
Prior art date
Application number
NO1992921472A
Other languages
English (en)
Other versions
NO921472L (no
NO303943B1 (no
Inventor
Vincent Racaniello
Joanne Marie Tatem
Carolyn L Weeks-Levy
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of NO921472L publication Critical patent/NO921472L/no
Publication of NO921472D0 publication Critical patent/NO921472D0/no
Publication of NO303943B1 publication Critical patent/NO303943B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO921472A 1990-08-20 1992-04-13 RNA-virus fra cDNA fra et vaksinestamme 3 poliovirus, rekombinant DNA-molekyl, vert og fremgangsmÕte for fremstilling av et terapeutisk aktivt levedyktig RNA-virus NO303943B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57000090A 1990-08-20 1990-08-20
US56991690A 1990-08-20 1990-08-20
PCT/US1991/005890 WO1992003538A1 (en) 1990-08-20 1991-08-20 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA

Publications (3)

Publication Number Publication Date
NO921472L NO921472L (no) 1992-04-13
NO921472D0 true NO921472D0 (no) 1992-04-13
NO303943B1 NO303943B1 (no) 1998-09-28

Family

ID=27075179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921472A NO303943B1 (no) 1990-08-20 1992-04-13 RNA-virus fra cDNA fra et vaksinestamme 3 poliovirus, rekombinant DNA-molekyl, vert og fremgangsmÕte for fremstilling av et terapeutisk aktivt levedyktig RNA-virus

Country Status (12)

Country Link
US (5) US5525715A (no)
EP (1) EP0496875B1 (no)
JP (1) JPH05503634A (no)
KR (1) KR100230195B1 (no)
AT (1) ATE212056T1 (no)
AU (1) AU656328B2 (no)
CA (1) CA2067337A1 (no)
DE (1) DE69132900D1 (no)
IL (1) IL99232A0 (no)
NO (1) NO303943B1 (no)
PT (1) PT98725B (no)
WO (1) WO1992003538A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (en) 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
DE69423313T2 (de) * 1993-12-20 2000-07-13 Seiko Epson Corp Elektronische Hinweisanordnung
US6071745A (en) * 1997-06-27 2000-06-06 Bio-Rad Laboratories Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
US6846655B1 (en) * 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
AU2001255379A1 (en) 2000-04-14 2001-10-30 The Uab Research Foundation Poliovirus replicons encoding therapeutic agents and uses thereof
US20030092035A1 (en) * 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
US20030040498A1 (en) * 2001-03-14 2003-02-27 Ansardi David Calvert Oncolytic RNA replicons
DK3307878T3 (da) * 2015-06-10 2021-10-11 Us Health Fremgangsmåder til fremstilling og oprensning af nukleinsyreholdige sammensætninger
EP3569618A1 (en) 2018-05-19 2019-11-20 Boehringer Ingelheim International GmbH Antagonizing cd73 antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor

Also Published As

Publication number Publication date
DE69132900D1 (de) 2002-02-21
US5580719A (en) 1996-12-03
EP0496875B1 (en) 2002-01-16
JPH05503634A (ja) 1993-06-17
NO921472L (no) 1992-04-13
IL99232A0 (en) 1992-07-15
PT98725B (pt) 1999-01-29
EP0496875A1 (en) 1992-08-05
CA2067337A1 (en) 1992-02-21
US5683901A (en) 1997-11-04
AU656328B2 (en) 1995-02-02
US6136570A (en) 2000-10-24
EP0496875A4 (en) 1993-12-29
US5525715A (en) 1996-06-11
US5834302A (en) 1998-11-10
KR100230195B1 (ko) 1999-11-15
KR920702411A (ko) 1992-09-04
NO303943B1 (no) 1998-09-28
AU8533391A (en) 1992-03-17
ATE212056T1 (de) 2002-02-15
WO1992003538A1 (en) 1992-03-05
PT98725A (pt) 1992-07-31

Similar Documents

Publication Publication Date Title
DK0690675T5 (da) Nukleinsyre, der koder for en tumorafstödningsantigenprecursor
NO910712D0 (no) Fremgangsmaate ved fremstilling av oksetanoner.
DK0575596T3 (da) Dendritisk makromolekyle og fremgangsmåde til fremstilling deraf
ATE453403T1 (de) Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert
ATE202487T1 (de) Mono- oder polyfunktionelle konjugate von polylysine
EA200200565A1 (ru) Применение клеток, трансфицированных днк, кодирующей лиганд мнс класса ii, и способ получения таких клеток
DE69106815D1 (de) Verfahren zur Herstellung von veränderten Kohlenstoffmolekularsieben zur Gastrennung.
NO921472L (no) Fremgangsmaate for fremstilling av rna-virus fra cdna
PT84155A (en) Method of modifying plant viruses or their effects
DE69028951T2 (de) Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen
MX9702524A (es) Virus atenuados y metodo para elaborarlos.
NO923918D0 (no) Nye t-celle-lymfom cdna-kloner
NO952576D0 (no) Vanillin- og/eller etylvanillinperler og fremgangsmåte for deres fremstilling
EP0831899A4 (en) RECOMBINANT POXVIRUS CALICIVIRUS / HEMORRHAGIC VIRUS FROM RABBIT (RHDV) COMPOSITIONS AND APPLICATIONS
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
DE69925863D1 (de) Verwendung eines sich ausdehnenden elementes
ES2084587T3 (es) Arn virus no revertientes.
HUP9901324A2 (hu) Eljárás triklór-butil-acetát előállítására

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003